Mutations in a Novel Factor, Glomulin, Are Responsible for Glomuvenous Malformations (“Glomangiomas”)

The American Journal of Human Genetics - Tập 70 - Trang 866-874 - 2002
Pascal Brouillard1, Laurence M. Boon1,2, John B. Mulliken3, Odile Enjolras4, Michella Ghassibé1, Matthew L. Warman5, O.T. Tan6, Bjorn R. Olsen7, Miikka Vikkula1
1Laboratory of Human Molecular Genetics, Christian de Duve Institute of Cellular Pathology and Université Catholique de Louvain, Brussels
2Center for Vascular Anomalies, Division of Plastic Surgery, Université catholique de Louvain, Brussels
3Division of Plastic Surgery, Children's Hospital, Boston
4Consultation des angiomes, hôpital Lariboisière, Paris
5Department of Genetics, Case Western Reserve University School of Medicine, Cleveland
6Tufts University School of Veterinary Medicine, Boston
7Department of Cell Biology, Harvard Medical School, and Harvard-Forsyth Department of Oral Biology, Harvard School of Dental Medicine, Boston

Tài liệu tham khảo

Boon, 1999, A gene for inherited cutaneous venous anomalies (“glomangiomas”) localizes to chromosome 1p21-22, Am J Hum Genet, 65, 125, 10.1086/302450 Boon, 1994, Assignment of a locus for dominantly inherited venous malformations to chromosome 9p, Hum Mol Genet, 3, 1583, 10.1093/hmg/3.9.1583 Brouillard, 2000, High-resolution physical and transcript map of the locus for venous malformations with glomus cells (VMGLOM) on chromosome 1p21-p22, Genomics, 67, 96, 10.1006/geno.2000.6232 Calvert, 2001, Additional glomangioma families link to chromosome 1p: no evidence for genetic heterogeneity, Hum Hered, 51, 180, 10.1159/000053340 Calvert, 1999, Allelic and locus heterogeneity in inherited venous malformations, Hum Mol Genet, 8, 1279, 10.1093/hmg/8.7.1279 Chambraud, 1996, FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12: prevention by the immunosuppressant drugs FK506 and rapamycin, J Biol Chem, 271, 32923, 10.1074/jbc.271.51.32923 Chen, 1997, Mechanism of TGFbeta receptor inhibition by FKBP12, EMBO J, 16, 3866, 10.1093/emboj/16.13.3866 Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2 Enjolras, 1996, Vascular cutaneous anomalies in children: malformations and hemangiomas, Pediatr Surg Int, 11, 290, 10.1007/BF00497795 Gallione, 1995, A gene for familial venous malformations maps to chromosome 9p in a second large kindred, J Med Genet, 32, 197, 10.1136/jmg.32.3.197 Goodman, 1971, Multiple glomus tumors: a clinical and electron microscopic study, Arch Dermatol, 103, 11, 10.1001/archderm.1971.04000130013002 Gorlin, 1960, Multiple glomus tumor of the pseudocavernous hemangioma type, Arch Dermatol, 82, 776, 10.1001/archderm.1960.01580050118018 Gupta, 1965, Multiple painful glomus tumors of the skin: views on histogenesis: case report, Arch Dermatol, 92, 670, 10.1001/archderm.1965.01600180062010 Hill, 1995, Transcriptional regulation by extracellular signals: mechanisms and specificity, Cell, 80, 199, 10.1016/0092-8674(95)90403-4 Hirschi, 1998, PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate, J Cell Biol, 141, 805, 10.1083/jcb.141.3.805 Irrthum, 2001, Linkage disequilibrium narrows locus for venous malformation with glomus cells (VMGLOM) to a single 1.48 Mbp YAC, Eur J Hum Genet, 9, 34, 10.1038/sj.ejhg.5200576 Kato, 1990, Localized form of multiple glomus tumors: report of the first case showing partial involution, J Dermatol, 17, 423, 10.1111/j.1346-8138.1990.tb01669.x Larsson, 2001, Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice, EMBO J, 20, 1663, 10.1093/emboj/20.7.1663 Miano, 2000, Serum response factor-dependent regulation of the smooth muscle calponin gene, J Biol Chem, 275, 9814, 10.1074/jbc.275.13.9814 Miettinen, 1983, Glomus tumor cells: evaluation of smooth muscle and endothelial cell properties, Virchows Arch B Cell Pathol Incl Mol Pathol, 43, 139, 10.1007/BF02932951 Mulliken, 1988, Vascular birthmarks: hemangiomas and malformations, 24 Nanaev, 1991, Immunofluorescent study of heterogeneity in smooth muscle cells of human fetal vessels using antibodies to myosin, desmin, and vimentin, Cell Tissue Res, 266, 535, 10.1007/BF00318595 Pepper, 1977, A new technique for cross sectioning free hairs, J Invest Dermatol, 68, 111, 10.1111/1523-1747.ep12491672 Rudolph, 1993, Familial multiple glomangiomas, Ann Plast Surg, 30, 183, 10.1097/00000637-199302000-00017 Shimizu, 1995, The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells, J Biol Chem, 270, 7631, 10.1074/jbc.270.13.7631 Vikkula, 1996, Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2, Cell, 87, 1181, 10.1016/S0092-8674(00)81814-0 Vikkula, 2001, Molecular genetics of vascular malformations, Matrix Biol, 20, 327, 10.1016/S0945-053X(01)00150-0 Vikkula, 1998, Molecular basis of vascular anomalies, Trends Cardiovasc Med, 8, 281, 10.1016/S1050-1738(98)00024-3 Yang, 1999, Embryonic mesenchymal cells share the potential for smooth muscle differentiation: myogenesis is controlled by the cell's shape, Development, 126, 3027, 10.1242/dev.126.13.3027